Feature | August 21, 2014

Study Results Show Heart Disease Deaths Dropped Significantly in Past Decade


August 21, 2014 — Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop in the rate of hospitalizations and deaths, according to a new study released in the journal Circulation. The results emphasize the value of recent efforts by the cardiovascular community to support the delivery of timely, high-quality care to patients.

The study, “Trends in Hospitalizations and Outcomes for Acute Cardiovascular Disease and Stroke: 1999-2011,” confirms that in the past decade hospitalization and death rates for heart disease and stroke have continued their significant declines despite the lack of any new practice-changing drug or biological treatments introduced over this same time period. According to the study’s authors, the new report is the most comprehensive look at America’s progress in preventing and treating heart disease to date. The study found U.S. hospitalization rates dropped significantly for cardiovascular disease patients from 1999-2011, including:

  • 38 percent drop among heart attack patients;
  • 83.8 percent decline among patients with unstable angina, or sudden and severe chest pain that may lead to a heart attack; and
  • The risk of dying within one year of hospitalization also dropped 21 percent for patients with unstable angina and 23 percent for heart attack patients.


“These declines coincide with rapid changes in attitudes about lifestyle, diet, exercise and smoking, at a time when cardiovascular medicine is leading the way in supporting evidence-based care through the use of data registries,” said Patrick O’Gara, M.D., FACC, president of the American College of Cardiology (ACC).Our goal is to see that these trends continue by encouraging healthy lifestyles and also by our support of performance measures for the entire cardiovascular team.”

“The new report shows we are continuing to make significant progress in improving heart disease outcomes as quality improvement initiatives expand,” said Charles Chambers, M.D., FSCAI, president of the Society for Cardiovascular Angiography and Interventions (SCAI) for 2014-15. “This is good news for patients and for the caregivers working hard to continuously improve care.”

The study was based on data from 34 million Medicare fee-for-service claims from 1999 through 2011. Researchers reviewed trends in hospitalization, dying within a month of admission, readmission within one month and dying within one year. They also compared patient demographics including age, sex, race, geography and co-existing conditions.

“The report shows cardiovascular outcomes are improving, to a point where one day, as the authors state, we may be able to remove cardiovascular disease from among the top causes of death and disability in this country,” Chambers said. “To make this a reality, it will be important to continue to work together and to ensure quality initiatives are implemented nationwide.”

For more information: www.scai.org, www.cardiosource.org/acc


Related Content

News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
News | Cardiovascular Clinical Studies

June 11, 2025 — Bayer and the Broad Institute have have extended their research collaboration of 10 years by an ...

Home June 11, 2025
Home
News | Cardiovascular Clinical Studies

May 27, 2025 — Despite scientific advances in cardiovascular care, people in living in rural areas and other communities ...

Home May 27, 2025
Home
News | Cardiovascular Clinical Studies

May 20, 2025 — Shockwave Medical, Inc., part of Johnson & Johnson MedTechhas announced the 30-day primary endpoint ...

Home May 21, 2025
Home
Subscribe Now